Learn / ADHD Medication
ADHD medication
ADHD medication, in plain language
What stimulant and non-stimulant ADHD medicines are for, what they commonly change, and where serious psychiatric effects sit in the evidence — uncommon, documented, not evenly distributed.
ADHD medicines are not a personality upgrade, a moral correction, or a diagnosis in a capsule. They are pharmacological tools that, for many people, change attentional regulation, impulse control and the amount of mental noise that has to be managed in order to start a task.
1 · Statement
For many people with ADHD, stimulant medicines can reduce core ADHD symptoms compared with placebo. That is a population finding, not a promise that a particular medicine will help a particular person.
2 · Classification
Established. Supported by network meta-analysis and clinical guidelines.
3 · Papers
4 · Claim limitation
Trials are short, selected, and do not capture every lived outcome that matters.
Last reviewed
1 September 2026
Stimulants
The main stimulant medicines used in Australia are lisdexamfetamine (Vyvanse), dexamfetamine, and methylphenidate (Ritalin, Concerta and related products). Pharmacologically they increase dopaminergic and noradrenergic signalling. Subjectively, some people report that a medicine classified as a stimulant makes the mind quieter. That is one of the apparent paradoxes this site exists to examine, not to dissolve with a slogan.
- Onset is often measured in hours, not weeks — unlike many antidepressants.
- Duration depends on the formulation. Immediate-release and long-acting products are not interchangeable experiences.
- Appetite reduction and delayed sleep are common. They are not trivial just because they are common.
- Heart rate and blood pressure deserve monitoring. This is ordinary clinical practice, not a scare.
- Irritability, rebound as the dose wears off, and headache are reported.
- Serious psychiatric reactions — including psychotic or manic symptoms — have been recorded. They are uncommon. Risk is not evenly distributed across all people, doses or medications.
1 · Statement
Prescription amphetamine treatment has been associated with an uncommon increased occurrence of psychotic symptoms compared with methylphenidate in a large observational study of young people. The events were uncommon in both groups. Association is not proof that amphetamine caused psychosis in any individual.
2 · Classification
Associated. Large new-user observational comparison; residual confounding remains possible.
3 · Papers
4 · Claim limitation
US claims data; uncommon outcome; not a randomised trial; not an Australian cohort.
Last reviewed
1 September 2026
Non-stimulants
Atomoxetine, guanfacine and, in some clinical situations, clonidine are not stimulants. They have different onset, different adverse-effect profiles, and they should not be described as medicines that can necessarily be stopped the same way some stimulant regimens are stopped. A later page on this site looks at cessation. The short version: do not treat “ADHD medication” as one object.
What they do not do
- They do not tell you whether you have ADHD.
- A strong response does not prove the diagnosis, and a weak response does not disprove it.
- They do not replace sleep, food, or a life that fits.
- They do not make antidepressant discontinuation disappear if that process is also underway.
Sources used on this page
- Australian ADHD Professionals Association (AADPA) (2022). Australian Evidence-Based Clinical Practice Guideline For Attention Deficit Hyperactivity Disorder (ADHD).
- National Institute for Health and Care Excellence (NICE) (2018). Attention deficit hyperactivity disorder: diagnosis and management (NG87).
- Cortese S, Adamo N, Del Giovane C, et al. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
- Moran LV, Ongur D, Hsu J, Castro VM, Perlis RH, Schneeweiss S (2019). Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
- Faraone SV, Banaschewski T, Coghill D, et al. (2021). The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.
Paradoxical.life provides evidence and self-documentation tools, not medical advice. If you have concerns about your health, medication or mental state, speak with a qualified medical practitioner.